🕵️ Anika Therapeutics, Inc. ($ANIK)
SEC insider & ownership activity, last 12 months · CIK 898437 · every row links its SEC filing
Over the last 12 months insiders bought $264K with no open-market selling against it. Stephen D. Griffin bought $150K in discretionary trades (Apr). BlackRock, Inc. trimmed 10.6% → 6.8%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $264K (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Stephen D. Griffin | 1 | $150K | 0 | – | Apr 30, 2026 |
| John B. Henneman III | 1 | $73K | 0 | – | May 1, 2026 |
| Gary P. Fischetti | 2 | $41K | 0 | – | Aug 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| David Johnson | 9.9% | 13D | Jan 23, 2026 | filing ↗ | |
| Caligan Partners LP | 9.9% | 13D | Jan 23, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.8% | 13G | Apr 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| William R. Jellison | $355K | Aug 7, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | Apr 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |